Suboxone tooth decay settlement values are commonly projected from about $10,000 to $150,000 per plaintiff, with the highest amounts for people who lost multiple teeth and needed extensive dental reconstruction. This Suboxone tooth decay settlement calculator estimates a payout from your dental-injury tier, restoration costs, related losses, and a pain-and-suffering multiplier. The cases are consolidated in the federal Suboxone (buprenorphine) multidistrict litigation (MDL 3092) before the U.S. District Court for the Northern District of Ohio. Use the calculator, then read how the dental science, the MDL, and damages combine to set Suboxone payouts.
Suboxone is a sublingual film containing buprenorphine and naloxone used to treat opioid use disorder. Plaintiffs allege that the film's acidic formulation, dissolved in the mouth one or more times daily for long periods, caused severe tooth decay, erosion, and tooth loss — and that the manufacturer (Indivior) failed to warn of this dental risk until the FDA required a label update in 2022.
No global Suboxone settlement existed as of 2026, so projected values combine a dental-injury tier with conventional damage math. The dominant driver is the extent of dental damage — the number of teeth lost and the cost of restoration. The calculator follows this logic:
Suboxone Estimate = Dental-Injury-Tier Anchor + Economic Damages (restoration + related losses) + Pain & Suffering (restoration × multiplier)
Cases requiring multiple extractions and full-mouth restoration (implants, dentures, or bridges) anchor the top tier. The loss of several teeth with crowns or implants anchors the middle tier. Moderate decay treated with fillings or root canals, and minor damage, anchor lower tiers. Dental records and treatment estimates are the key evidence.
| Tier | Dental Damage | Projected Range |
|---|---|---|
| Tier 1 | Multiple extractions / full-mouth restoration | ~$75,000 – $150,000 |
| Tier 2 | Several teeth lost, crowns/implants | ~$40,000 – $90,000 |
| Tier 3 | Moderate decay, fillings/root canals | ~$15,000 – $50,000 |
| Tier 4 | Minor dental damage | ~$5,000 – $20,000 |
In June 2022, the U.S. Food and Drug Administration added a warning to buprenorphine medicines dissolved in the mouth about the risk of serious dental problems, including tooth decay, cavities, and loss, even in patients with no prior dental issues. That warning is central to the litigation: plaintiffs allege the manufacturer should have warned years earlier. Federal cases are centralized in MDL 3092 before Judge J. Philip Calabrese in the Northern District of Ohio. As of 2026 the litigation was in pretrial stages, with the court managing discovery and a key issue being the statute of limitations — whether claims filed after the 2022 warning are timely. Bellwether trials are expected to shape any settlement framework.
Suppose a long-term Suboxone film user who lost most of their teeth and needs full-mouth implants (Tier 1) faces $60,000 in restoration costs, $5,000 in related losses, and a pain-and-suffering multiplier of 2.5. The calculator computes economic damages of $65,000 and pain-and-suffering of $150,000 (restoration × 2.5), for a formula value of $215,000, which is capped near the Tier 1 ceiling band and displayed with a likely range below it. A Tier 3 user with moderate decay, $20,000 in dental costs, and a multiplier of 2 would land near that tier's anchor. Restoration cost and the number of teeth lost are the decisive factors.
Under IRS Publication 4345, compensatory damages for a personal physical injury — including dental injury and tooth loss — are generally excluded from taxable income. Interest and any punitive damages are taxable, and amounts allocated to non-physical claims may be treated differently. Confirm your specific tax treatment with a qualified professional.
A Suboxone tooth decay claim starts with gathering dental records that show the decay, extractions, and recommended restoration, along with pharmacy records proving sublingual film use. The case is filed into MDL 3092 in the Northern District of Ohio, joining others for coordinated discovery. A central early issue is the statute of limitations — whether claims filed after the June 2022 FDA warning are timely — so the court must resolve that gateway question. Bellwether trials then test how juries value the dental injuries, and any settlement matrix follows, tiering claims by the number of teeth affected and restoration needed. Payments are distributed over time, net of fees, costs, and liens.
Suboxone cases are generally contingency-based, with the attorney earning a percentage of any recovery (commonly 33% to 40%) plus case costs. Dental insurers or public programs may assert liens for restoration they paid, repaid from the settlement but often negotiable. This calculator estimates a gross value; the net is what remains after fees, costs, and liens. For example, on a $90,000 gross Suboxone settlement with a 38% fee, $5,000 in costs, and a $7,000 lien, the net would be roughly $48,000. Because the dollar amounts here are smaller than in some mass torts, the fee structure has a meaningful effect on net recovery — ask for a written breakdown.
A Suboxone estimate can be lowered by poor pre-existing dental health, which gives defendants an alternative-cause argument, or by short-duration film use that weakens the causal link. Use of a non-film formulation, gaps in dental records, or difficulty showing the timeline between film use and decay can also reduce value. The statute-of-limitations issue is especially important: a claim filed too long after the connection became apparent may be barred. Because no settlement matrix existed as of 2026, values remain projections tied to the bellwether outcomes. Do not stop taking prescribed Suboxone over the lawsuit; discuss dental concerns with your prescriber and dentist.
This Suboxone tooth decay settlement calculator is intended for patients who used Suboxone (or generic buprenorphine/naloxone) sublingual film to treat opioid use disorder and subsequently suffered significant dental damage — tooth decay, enamel erosion, cavities, broken teeth, or tooth loss. It is most relevant to those who had relatively good dental health before starting the film and who used it daily over an extended period. Patients who used a non-film formulation, or whose dental problems have clear alternative causes, may find their claims weaker and should treat the tool as a starting point. Anyone considering a claim should act promptly because of the litigation's statute-of-limitations issues tied to the June 2022 FDA warning.
The essentials of Suboxone dental claims are these. The extent of dental damage — the number of teeth lost and the cost of restoration — drives value, with full-mouth reconstruction anchoring the top tier. The June 2022 FDA dental warning is the litigation's anchor and the reference point for timeliness. Good pre-existing dental health strengthens causation; alternative causes weaken it. The cases are consolidated in MDL 3092 in Ohio, with no settlement matrix as of 2026, so values are projections. The gross estimate is reduced by attorney fees, costs, and liens. And critically, never stop taking prescribed Suboxone over the lawsuit — discuss dental concerns with your prescriber and dentist while pursuing your claim.
Projected Suboxone settlement values range from roughly $10,000 to $150,000, with the highest amounts for people who lost multiple teeth and needed full-mouth reconstruction. No global settlement had been finalized as of 2026, so these are projections based on dental-injury tiers and bellwether expectations in MDL 3092. Actual value depends on the number of teeth affected, restoration cost, duration of film use, and pain.
In June 2022, the FDA added a warning that buprenorphine medicines dissolved in the mouth — including Suboxone film — can cause serious dental problems such as tooth decay, cavities, and tooth loss. The acidic film, held in the mouth one or more times daily for long periods, is alleged to erode enamel. Plaintiffs claim the manufacturer should have warned of this risk earlier.
Generally, people who used Suboxone (or generic buprenorphine/naloxone) sublingual film and later suffered significant tooth decay, erosion, or tooth loss may qualify, particularly with good prior dental health. The litigation focuses on the dissolvable film formulation. An attorney evaluates your dental records, duration of use, and the timing of your claim against the statute of limitations.
MDL 3092 is the federal Suboxone (buprenorphine) multidistrict litigation centralized before Judge J. Philip Calabrese in the U.S. District Court for the Northern District of Ohio. It consolidates the dental-injury cases for coordinated pretrial proceedings and bellwether trials, which help set a framework for resolving the remaining claims.
It depends on your state's statute of limitations and when you connected your dental injuries to Suboxone, often measured from the June 2022 FDA warning. The statute of limitations is a central issue in the litigation, and some deadlines may be near or passed. Because timing is critical, consult an attorney promptly to preserve your rights.
No — do not stop a prescribed medication based on a lawsuit. Suboxone treats opioid use disorder, and stopping abruptly can be dangerous. The FDA advises patients to maintain good oral hygiene and discuss dental concerns with their doctor and dentist, not to discontinue treatment on their own. Talk to your prescriber about any concerns.
Under IRS Publication 4345, compensatory damages for a physical injury such as dental damage are generally not taxable. Interest and punitive damages are taxable, and non-physical-injury portions may be treated differently. Confirm the treatment of your specific payout with a tax professional.